Skip to main content
. 2018 Oct 12;15(1):167–178. doi: 10.1080/21645515.2018.1520584

Table 1.

(A) Disease type and HLA-A2 status of patients recruited in this study. (B) Demographic data of HLA-A2 patients.

Variables Sample size, n (%)
A
Total patients 41 (100.0)
Disease  
 NPC 29 (70.7)
 OSCC 12 (29.3)
HLA type  
 A2 20 (48.8)
 Non A2 21 (51.2)
B
Disease  
 NPC 16 (80.0)
 OSCC 4 (20.0)
Age (median, 48.5; range, 30–67)  
 ≤ 40 3 (15.0)
 > 40 17 (85.0)
Ethnicity  
 Chinese 16 (80.0)
 Malay 2 (10.0)
 Indian 2 (10.0)
Gender  
 Male 17 (85.0)
 Female 3 (15.0)
Overall staging  
 Early stage (Stage I and II) 4 (20.0)
 Late stage (Stage III and IV) 16 (80.0)